Alkem Laboratories Limited (ALKEM) — Announcement

· NSE Neutral
📢 Key Event
Alkem Laboratories schedules analyst and institutional investor meeting for June 16, 2026
💡 Investor Takeaway
Investors should note the meeting is a routine engagement with no financial updates or guidance provided.

Alkem Laboratories announced its upcoming analyst and institutional investor meeting scheduled for June 16, 2026, in Mumbai, inviting one-on-one sessions with investors. The filing confirms the meeting type and location but provides no financial results, guidance, or performance metrics. This routine update informs investors of a planned engagement opportunity without altering recent operational or financial conditions.

📄 View Original Announcement (PDF)

About Alkem Laboratories Limited (ALKEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹65,593.36 Cr P/E: 27.7 ROE: 19.8% ROCE: 22.1%

View full ALKEM stock details →

📡 Get AI alerts when ALKEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ALKEM — Free

📊 More ALKEM filings

See all ALKEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ALKEM files new disclosures

Track ALKEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ALKEM — Free

Free account · 2 AI queries/day